Long-term changes in adipose tissue in human disease

Proceedings of the Nutrition Society

Volumn 60, Issue 3, 2001, Pages 365-374

  Pond, C M ^a  

^a OPEN UNIVERSITY   (United Kingdom)

Author keywords

Antiretroviral drugs; Crohn's disease; HIV; HIV adipose redistribution syndrome; Perinodal adipocytes

Indexed keywords

ANTIRETROVIRUS AGENT; CYTOKINE; INTERLEUKIN 4; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; ZIDOVUDINE;

ADIPOCYTE; ADIPOSE TISSUE; CHRONIC DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; CROHN DISEASE; DRUG INDUCED DISEASE; GASTROINTESTINAL DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INSULIN RESISTANCE; LIPODYSTROPHY; LYMPH NODE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; TISSUE DISTRIBUTION; VIRUS INFECTION;

ALPHAVIRUS; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0034890057     PISSN: 00296651     EISSN: None     Source Type: Journal    
DOI: 10.1079/PNS200198     Document Type: Conference Paper

References (71)

1. Lipodystrophy syndrome in HIV infection. What is it, what causes it and how can it be managed?
2. The regulation of adipose-tissue distribution in humans
3. Body fat distribution, insulin resistance, and metabolic diseases
4. Mitochondrial toxicity of nucleoside analogue reverse transcriptase inhibitors: A looming obstacle for long-term antiretroviral therapy?
5. Dietary fatty acids and the immune system
6. HIV protease inhibitor-related lipodystrophy syndrome
7. The role of stress and the hypothalamic-pituitary-adrenal axis in the pathogenesis of the metabolic syndrome: Neuroendocrine and target tissue-related causes
8. Regional ileitis, a pathologic and clinical entity
9. Cytokine response in multiple lymphoid tissues during the primary phase of feline immunodeficiency virus infection
10. Effects of protein-energy malnutrition and human immunodeficiency virus-1 infection on essential fatty acid metabolism in children
11. AZT treatment induces molecular and ultrastructural oxidative damage to muscle mitochondria: Prevention by antioxidant vitamins
12. Inflammatory alterations in mesenteric adipose tissue in Crohn's disease
13. Association of adenovirus infection with human obesity
14. Changes in body habitus and serum lipid abnormalities in HIV-positive women on highly active antiretroviral therapy (HAART)
15. Infection and coronary heart disease
16. Fat distribution in HIV-infected patients reporting truncal enlargement quantified by whole-body magnetic resonance imaging
17. Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency
18. ob gene mutations and human obesity
19. Parasites, bright males, and the immunocompetence handicap
20. Visceral fat and insulin resistance - Causative or correlative?
21. Amino acid metabolism in human subcutaneous adipose tissue in vivo
22. Fat intake and fatty acid profile in plasma phospholipids and adipose tissue in patients with Crohn's disease, compared with controls
23. Fetal mitochondrial heart and skeletal muscle damage in Erythrocebus patas monkeys exposed in utero to 3′-azido-3′deoxythymidine
24. Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy
25. The function of adipocytes in the bone marrow stroma: An update
26. Tumor necrosis factor, interleukin, and interferon induced changes in lipid metabolism as part of host defense
27. Metabolic and anthropometric consequences of interruption of highly active antiretroviral therapy
28. The relationship between schizophrenia, essential fatty acids and eicosanoid metabolism
29. Clinical and metabolic presentation of the lipodystrophic syndrome in HIV-infected children
30. Immunological memory and acquired immunodeficiency syndrome pathogenesis
31. The effects of human immunodeficiency virus in the central nervous system
32. Studies of body composition and fat distribution in HIV-infected and control subjects
33. Fatty acids and schizophrenia
34. Human immunodeficiency virus infection and Crohn's disease: The role of the CD4 cell in inflammatory bowel disease
35. Changes in body-composition and adipose tissue distribution after treatment of women with Cushing's syndrome
36. Mucosal substance P receptor expression in HIV infection and inflammatory bowel disease
37. Dietary fatty acids influence the appearance of tumour necrosis factor-α receptors on adipocytes following an immune challenge
38. Lipodystrophy in patients naive to HIV protease inhibitors
39. The effects of feeding suet-enriched chow on site-specific differences in the composition of triacylglycerol-fatty acids in adipose tissue and its interactions in vitro with lymphoid cells
40. Interactions of noradrenalin and tumour necrosis factor-α, interleukin-4 and interleukin-6 in the control of lipolysis from adipocytes around lymph nodes
41. HIV-associated lipodystrophy syndrome
42. Nutrition in paediatric human immunodeficiency virus infection
43. On the etiology of Crohn disease
44. Adipose tissue as an endocrine and paracrine organ
45. IL-4 hyporesponsiveness of Crohn's disease mucosal T lymphocytes: A response of polarised Th1 cells?
46. Clinical manifestations and management of antiretroviral nucleoside analog-related mitochondrial toxicity
47. Lipodystrophy associated with protease inhibitors
48. Bone mineral density in patients with human immunodeficiency virus infection
49. Genetics of inflammatory bowel disease - The candidate gene approach: Susceptibility versus disease heterogeneity
50. Physiological specialisation of adipose tissue
51. Interactions between adipose tissue around lymph nodes and lymphoid cells in vitro
52. In vivo evidence for the involvement of the adipose tissue surrounding lymph nodes in immune responses
53. Modifications induced by dietary lipid source in adipose tissue phospholipid fatty acids and their consequences for lipid mobilization
54. Fat distribution and metabolic changes in patients with HIV infection
55. A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy
56. Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: Preliminary results of the LIPOCO study
57. Disorders of fat distribution in HIV infection
58. Fat-wrapping in Crohn's disease: Pathological basis and relevance to surgical practice
59. Adaptive significance of female physical attractiveness: The role of waist-to-hip ratio
60. Female health, attractiveness, and desirability for relationships: Role of breast asymmetry and waist-to-hip ratio
61. Female judgment of male attractiveness and desirability for relationships: Role of waist-to-hip ratio and financial status
62. Sex differences in the anatomical locations of human body scarification and tattooing as a function of pathogen prevalence
63. Ethnic and gender consensus for the effect of waist-to-hip ratio on judgment of women's attractiveness
64. Body weight, waist-to-hip ratio, breasts, and hips: Role in judgments of female attractiveness and desirability for relationships
65. Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy
66. Leptin and interleukin-6 in sepsis
67. Diabetes Insulin resistance and dyslipidaemia in lipodystrophic HIV-infected patients on highly active antiretroviral therapy (HAART)
68. Endogenous retroviruses and schizophrenia
69. Disease, endocrine-immune interactions, and sexual selection